Reference : Towards a Typology of Business Models in the Biotechnology Industry
E-prints/Working papers : Already available on another site
Business & economic sciences : Strategy & innovation
http://hdl.handle.net/2268/216110
Towards a Typology of Business Models in the Biotechnology Industry
English
Segers, Jean Pierre mailto [Université de Liège - ULiège > > > Doct. sc. éco. & gest. (sc. gestion - paysage)]
11-Jan-2018
SSRN (Elsevier)
Sources of Innovation eJournal
Yes
[en] Biotechnology ; Open Innovation ; Business Models
[en] The purpose of this paper is to identify a selection of key business models - “typology” - applied in the biotechnology industry. The focus is on the differences between traditional/closed or stand-alone business models opposed to open or networked business models.
A number of illustrative case studies and good practices are presented to show that new biotechnology firms are gradually adopting a “best of both worlds” strategy, with both closed business models and open, networked models as a way for gaining access to the market, in close collaboration with large global pharmaceutical companies. The case firms and good practices are taken from a recent country study for Belgium.
http://hdl.handle.net/2268/216110
10.13140/RG.2.2.14753.51046/1
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3065300

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Typology Biotech BM (Segers).pdfAuthor preprint684 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.